BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/14/2025 12:56:13 AM | Browse: 75 | Download: 201
 |
Received |
|
2025-05-27 02:03 |
|
Peer-Review Started |
|
2025-05-27 02:03 |
|
First Decision by Editorial Office Director |
|
2025-06-06 03:30 |
|
Return for Revision |
|
2025-06-06 03:30 |
|
Revised |
|
2025-06-14 09:12 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-09-24 02:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-09-24 08:35 |
|
Articles in Press |
|
2025-09-24 08:35 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-11-05 00:36 |
|
Publish the Manuscript Online |
|
2025-11-14 00:56 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Targeting the Osteopontin-regulated PI3K/AKT signaling pathway: A molecular approach to overcome drug resistance and metastasis in gastrointestinal tumors
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Hui Nian, Yu Bai, Hong-Yang Wang, Hua Yu, Zhi-Long Zhang, Ru-Hong Shi, Shu Zhang, Yi-Bin Wu, De-Hua Zhou and Qian-Cheng Du |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Hongkou District Health Commission of Shanghai Municipality |
"Hongwei" 2303-10 |
|
| Corresponding Author |
Qian-Cheng Du, MD, Department of Thoracic Surgery, Shanghai Xuhui Central Hospital, No. 366 Longchuan North Road, Xuhui District, Shanghai 200031, China. duqc1991106@sina.com |
| Key Words |
Osteopontin; Gastrointestinal cancers; Chemoresistance; Targeted therapy; Tumor microenvironment remodeling |
| Core Tip |
Osteopontin (OPN) drives gastrointestinal tumor progression by activating the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathway, promoting proliferation, metastasis, chemoresistance, and immune evasion. Key mechanisms involve upregulating anti-apoptotic proteins (e.g., B-cell lymphoma 2), inducing epithelial-mesenchymal transition via Snail/Twist, and remodeling the tumor microenvironment through VEGF-driven angiogenesis and cluster of differentiation 44-mediated immune suppression. Targeting this axis with PI3K/AKT inhibitors (e.g., Alpelisib) or OPN-neutralizing antibodies may reverse drug resistance and suppress metastasis. Challenges include pathway redundancy and the need for biomarker-guided precision strategies. Future research should focus on OPN isoform specificity, combination therapies (e.g., with immune checkpoint inhibitors), and multi-omics approaches to optimize outcomes in refractory cancers. |
| Publish Date |
2025-11-14 00:56 |
| Citation |
Nian H, Bai Y, Wang HY, Yu H, Zhang ZL, Shi RH, Zhang S, Wu YB, Zhou DH, Du QC. Targeting the Osteopontin-regulated PI3K/AKT signaling pathway: A molecular approach to overcome drug resistance and metastasis in gastrointestinal tumors. World J Gastrointest Oncol 2025; 17(11): 109923 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i11/109923.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i11.109923 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
